European Medicines Agency starts rolling review of Sinovac vaccine
1 min
The European Medicines Agency (EMA) has announced the start of the rolling review of the Chinese vaccine from Sinovac, the so-called CoronaVac. This is an inactivated one. It works by using killed viral particles to expose the body's immune system to the virus without risking a disease reaction.
